Conference Coverage

Increased surveillance may explain post-Fukushima pediatric thyroid cancers

Publish date: October 30, 2015

 

AT ITC 2015

References

Dr. Suzuki reported no relevant disclosures.

koakes@frontlinemedcom.com

On Twitter @karioakes

Pages

Recommended Reading

Tumor location, radiotherapy predict neuroendocrine dysfunction after pediatric glioma
MDedge Hematology and Oncology
ESTIMABL trial: Current rhTSH cost outweighs benefits
MDedge Hematology and Oncology
Obesity linked with more aggressive papillary thyroid carcinoma
MDedge Hematology and Oncology
Cabozantinib boosts survival for some patients with RET+ medullary thyroid cancer
MDedge Hematology and Oncology
ITC 2015: TIRADS scoring helps sort out malignancy after fine-needle aspiration of thyroid nodule
MDedge Hematology and Oncology
Cabozantinib shows promise in refractory differentiated thyroid cancer
MDedge Hematology and Oncology
Thyroglobulin can’t predict pazopanib response in differentiated thyroid cancer
MDedge Hematology and Oncology
Study finds no link between thyroid autoimmunity, breast cancer outcomes
MDedge Hematology and Oncology
ITC: SELECT trial: Lenvatinib effects similar regardless of site, number of metastases
MDedge Hematology and Oncology
Percutaneous ethanol effective for small papillary thyroid cancers
MDedge Hematology and Oncology